Press Releases

Date Title and Summary Additional Formats
Toggle Summary Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2016
RANCHO CUCAMONGA, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2016 ended March 31, 2016, after the market closes on Monday, May 9, 2016, and will hold a conference call to discuss its
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
RANCHO CUCAMONGA, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 15 th Annual Needham Healthcare Conference on Wednesday, April 13, 2016 at 12:50 p.m.
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2015
Reports Net Revenues of $76.9 Million for the Fourth Quarter Ended December 31, 2015
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 14, 2016
RANCHO CUCAMONGA, Calif., March 11, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2015 ended December 31, 2015, after the market closes on Monday, March 14, 2016, and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthcare Conference
RANCHO CUCAMONGA, Calif. , Nov. 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Jason Shandell , President and Bill Peters , CFO will be presenting at the 27 th Annual Piper Jaffray Healthcare Conference on Tuesday,
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Net Revenues of $63.9 Million for the Third Quarter Ended September 30, 2015
RANCHO CUCAMONGA, Calif. , Nov. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the third quarter ended September 30, 2015 . Net revenues of $63.9 million for the third quarter GAAP net loss of $3.0 million , or
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 12, 2015
RANCHO CUCAMONGA, Calif. , Nov. 5, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2015 ended September 30, 2015 , after the market closes on Thursday, November 12, 2015 , and will hold a conference call
View HTML
Toggle Summary Amphastar Pharmaceuticals Launches Amphadase(R)
RANCHO CUCAMONGA, Calif. , Oct. 20, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that it began shipping Amphadase ® (hyaluronidase injection). This launch marks the first product made using starting material from the Company's
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Net Revenues of $53.9 Million for the Second Quarter Ended June 30, 2015
RANCHO CUCAMONGA, Calif. , Aug. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2015 . Net revenues of $53.9 million for the second quarter GAAP net loss of $6.6 million , or $0.15
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 12, 2015
RANCHO CUCAMONGA, Calif. , Aug. 4, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2015 ended June 30, 2015 , after the market closes on Wednesday, August 12, 2015 , and will hold a conference call to
View HTML

 

Copyright ©2018 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States